EP1593671A1 — DPP-IV inhibitors
Assigned to Graffinity Pharmaceuticals AG · Expires 2005-11-09 · 21y expired
What this patent protects
The invention relates to compounds of formula (I) Z-C(R<1>R<2>)-C(R<3>NH2)-C(R<4>R<5>)-X-N(R<6>R<7>) wherein Z, R<1-7> and X have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors…
USPTO Abstract
The invention relates to compounds of formula (I) Z-C(R<1>R<2>)-C(R<3>NH2)-C(R<4>R<5>)-X-N(R<6>R<7>) wherein Z, R<1-7> and X have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.